Literature DB >> 11337521

Use of (99m)Tc-labeled liposomes encapsulating blue dye for identification of the sentinel lymph node.

W T Phillips1, R Klipper, B Goins.   

Abstract

UNLABELLED: Colloidal radiopharmaceuticals are commonly used in combination with blue dye for localization of the sentinel node. Liposomes are colloidal particles composed of spontaneously forming lipid spheres that can carry a wide variety of diagnostic and therapeutic agents. Conventional liposomes are poorly retained in lymph nodes (<2% of the subcutaneously injected dose). We have previously described a system for increasing the retention of liposomes in the lymph nodes by approximately 7-fold. This system is comprised of subcutaneously injected biotin-coated liposomes, followed by an adjacent injection of avidin. When the avidin moves into the lymphatic vessels, it causes aggregation of the biotin-coated liposomes that are also in the process of migrating through the lymphatic vessels. These aggregated liposomes become entrapped in the next encountered lymph node. In this study, we use this novel lymph node delivery system with liposomes that encapsulate blue dye, resulting in intense blue staining of the sentinel node. These liposomes can also be labeled with (99m)Tc, permitting scintigraphic imaging and radioguided probe localization of the sentinel node.
METHODS: Liposomes coated with biotin and coencapsulating blue dye and glutathione were labeled with (99m)Tc using hexamethylpropyleneamine oxime. Rabbits were subcutaneously administered 0.3 mL (99m)Tc-biotin-liposomes containing blue dye in both hind feet, followed by a subcutaneous injection (0.3 mL) of 5 mg avidin in only one hind foot (experimental). The other hind foot served as a control.
RESULTS: Labeling efficiencies (mean +/- SEM) for liposomes encapsulating blue dye were 92.1% +/- 1.9%. Necropsy at 24 h revealed that the popliteal node on the experimental leg receiving the avidin was intensely blue stained compared with virtually no blue coloration of the control node. Tissue counts of these nodes were 12.2 +/- 1.5 percentage injected dose (%ID) in the experimental node compared with 1.2 +/- 0.1 %ID in the control nodes (P<0.0001).
CONCLUSION: Biotin-liposomes encapsulating blue dye can be successfully labeled with (99m)Tc, providing a convenient option for the visualization and radiolocalization of the sentinel node. This biotin-liposome/avidin system may also have potential for the delivery of therapeutic drugs and radiopharmaceuticals to lymph nodes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11337521

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  8 in total

Review 1.  Enabling individualized therapy through nanotechnology.

Authors:  Jason H Sakamoto; Anne L van de Ven; Biana Godin; Elvin Blanco; Rita E Serda; Alessandro Grattoni; Arturas Ziemys; Ali Bouamrani; Tony Hu; Shivakumar I Ranganathan; Enrica De Rosa; Jonathan O Martinez; Christine A Smid; Rachel M Buchanan; Sei-Young Lee; Srimeenakshi Srinivasan; Matthew Landry; Anne Meyn; Ennio Tasciotti; Xuewu Liu; Paolo Decuzzi; Mauro Ferrari
Journal:  Pharmacol Res       Date:  2010-01-05       Impact factor: 7.658

2.  Noninvasive photoacoustic and fluorescence sentinel lymph node identification using dye-loaded perfluorocarbon nanoparticles.

Authors:  Walter J Akers; Chulhong Kim; Mikhail Berezin; Kevin Guo; Ralph Fuhrhop; Gregory M Lanza; Georg M Fischer; Ewald Daltrozzo; Andreas Zumbusch; Xin Cai; Lihong V Wang; Samuel Achilefu
Journal:  ACS Nano       Date:  2010-12-20       Impact factor: 15.881

Review 3.  Animal models and molecular imaging tools to investigate lymph node metastases.

Authors:  Elliot L Servais; Christos Colovos; Adam J Bograd; Julie White; Michel Sadelain; Prasad S Adusumilli
Journal:  J Mol Med (Berl)       Date:  2011-05-10       Impact factor: 4.599

Review 4.  Radiolabeled nanomaterials for biomedical applications: radiopharmacy in the era of nanotechnology.

Authors:  Martha Sahylí Ortega Pijeira; Herlys Viltres; Jan Kozempel; Michal Sakmár; Martin Vlk; Derya İlem-Özdemir; Meliha Ekinci; Seshasai Srinivasan; Amin Reza Rajabzadeh; Eduardo Ricci-Junior; Luciana Magalhães Rebelo Alencar; Mohammed Al Qahtani; Ralph Santos-Oliveira
Journal:  EJNMMI Radiopharm Chem       Date:  2022-04-25

Review 5.  Theranostic Nanoparticles for Tracking and Monitoring Disease State.

Authors:  Cristina Zavaleta; Dean Ho; Eun Ji Chung
Journal:  SLAS Technol       Date:  2017-11-08       Impact factor: 3.047

Review 6.  Intraoperative mapping of sentinel lymph node metastases using a clinically translated ultrasmall silica nanoparticle.

Authors:  Michelle S Bradbury; Mohan Pauliah; Pat Zanzonico; Ulrich Wiesner; Snehal Patel
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-12-10

Review 7.  Molecular Imaging and Nanotechnology-Emerging Tools in Diagnostics and Therapy.

Authors:  Marcin Woźniak; Agata Płoska; Anna Siekierzycka; Lawrence W Dobrucki; Leszek Kalinowski; Iwona T Dobrucki
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

8.  The Formulation of Methylene Blue Encapsulated, Tc-99m Labeled Multifunctional Liposomes for Sentinel Lymph Node Imaging and Therapy.

Authors:  Mine Sİlİndİr GÜnay
Journal:  Turk J Pharm Sci       Date:  2020-08-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.